- Home
- CVKD vs IPM Comparison
CVKD vs IPM Comparison
Compare CVKD & IPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVKD
- IPM
- Stock Information
- Founded
- CVKD 2022
- IPM 2005
- Country
- CVKD United States
- IPM United States
- Employees
- CVKD N/A
- IPM N/A
- Industry
- CVKD Medicinal Chemicals and Botanical Products
- IPM
- Sector
- CVKD Health Care
- IPM
- Exchange
- CVKD Nasdaq
- IPM NYSE
- Market Cap
- CVKD 29.5M
- IPM 27.9M
- IPO Year
- CVKD 2023
- IPM N/A
- Fundamental
- Price
- CVKD $10.54
- IPM $2.01
- Analyst Decision
- CVKD Strong Buy
- IPM Strong Buy
- Analyst Count
- CVKD 1
- IPM 1
- Target Price
- CVKD $32.00
- IPM $6.00
- AVG Volume (30 Days)
- CVKD 27.7K
- IPM 32.5K
- Earning Date
- CVKD 08-11-2025
- IPM 08-13-2025
- Dividend Yield
- CVKD N/A
- IPM N/A
- EPS Growth
- CVKD N/A
- IPM N/A
- EPS
- CVKD N/A
- IPM N/A
- Revenue
- CVKD N/A
- IPM $6,344,746.00
- Revenue This Year
- CVKD N/A
- IPM $1,957.49
- Revenue Next Year
- CVKD N/A
- IPM $17.96
- P/E Ratio
- CVKD N/A
- IPM N/A
- Revenue Growth
- CVKD N/A
- IPM 14.16
- 52 Week Low
- CVKD $5.70
- IPM $1.52
- 52 Week High
- CVKD $22.90
- IPM $5.50
- Technical
- Relative Strength Index (RSI)
- CVKD 37.37
- IPM N/A
- Support Level
- CVKD $11.25
- IPM N/A
- Resistance Level
- CVKD $11.88
- IPM N/A
- Average True Range (ATR)
- CVKD 0.77
- IPM 0.00
- MACD
- CVKD -0.03
- IPM 0.00
- Stochastic Oscillator
- CVKD 2.95
- IPM 0.00
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.
About IPM INTELLIGENT PROTECTION MANAGEMENT
Intelligent Protection Management Corp is a communications software innovator that powers multimedia social applications.